---
ver: rpa2
title: 'Breaking Down the Hierarchy: A New Approach to Leukemia Classification'
arxiv_id: '2502.10899'
source_url: https://arxiv.org/abs/2502.10899
tags:
- leukemia
- classi
- cation
- hierarchical
- acute
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: This study introduces a hierarchical deep learning approach to
  classify leukemia subtypes from blood smear images, addressing limitations of manual
  analysis and expert bias. The proposed method uses a multi-level structure inspired
  by clinical diagnosis, employing both Convolutional Neural Networks (ConvNeXt) and
  Vision Transformers (ViT) as classifiers.
---

# Breaking Down the Hierarchy: A New Approach to Leukemia Classification

## Quick Facts
- **arXiv ID**: 2502.10899
- **Source URL**: https://arxiv.org/abs/2502.10899
- **Reference count**: 26
- **Primary result**: Hierarchical deep learning approach achieves ~90% accuracy for classifying 7 leukemia subtypes from blood smear images

## Executive Summary
This study introduces a hierarchical deep learning approach for classifying leukemia subtypes from blood smear images, addressing limitations of manual analysis and expert bias. The method organizes classification into sequential stages inspired by clinical diagnosis, using both Convolutional Neural Networks (ConvNeXt) and Vision Transformers (ViT) as classifiers. Experiments on a unique Middle East dataset achieved approximately 90% accuracy across all leukemia subtypes, with the ViT-Small architecture performing best. The hierarchical structure demonstrated superior precision and recall compared to flat classification, particularly for differentiating visually similar classes.

## Method Summary
The proposed method uses a multi-level hierarchical structure for leukemia classification. The system is organized into three sequential levels: first distinguishing between normal, reactive, and leukemia cells; then identifying acute vs. chronic forms; and finally determining specific subtypes (ALL, AML, APML, CLL, CML). Two approaches were compared: a base hierarchical model with four separate models per hierarchy level, and a proposed multi-label hierarchical model with a single sequential model containing self-contained loss per level. The architecture employs ConvNeXt-Tiny and ViT-Small backbones with Focal Loss, AdamW optimizer (learning rate 1×10⁻⁶), and 80 training epochs.

## Key Results
- Achieved 90.97% accuracy using ViT-Small on 7-class hierarchical classification
- Hierarchical structure improved differentiation between visually similar classes compared to flat classification
- Visual analysis using Grad-CAM confirmed accurate localization of white blood cells, particularly in the hierarchical approach
- The model successfully handled the classification of leukemia subtypes with enhanced precision and recall

## Why This Works (Mechanism)
The hierarchical approach mirrors clinical diagnosis by breaking down the complex classification task into sequential, more manageable decisions. By organizing the classification into levels that progressively refine the diagnosis, the model reduces the cognitive load at each stage and improves accuracy for visually similar classes. The use of self-contained loss per hierarchy level prevents cross-layer interference during training, while the sequential inference process ensures logical progression through the diagnostic pathway.

## Foundational Learning
- **Hierarchical classification**: Organizing complex classification tasks into sequential stages to improve accuracy and interpretability; needed because flat classification struggles with visually similar classes.
- **Vision Transformers vs. ConvNeXt**: Different deep learning architectures for image analysis; needed because comparing architectures validates robustness and identifies optimal performer.
- **Focal Loss**: A loss function that addresses class imbalance by down-weighting well-classified examples; needed because leukemia datasets often have imbalanced class distributions.
- **Grad-CAM visualization**: A technique for visualizing model decision-making by highlighting important regions in input images; needed to verify the model is focusing on relevant white blood cells.

## Architecture Onboarding

**Component Map**: Input Images (384×384) → Hierarchical Model (3-level) → Classification Outputs (7 classes)

**Critical Path**: Input → Level 1 (3-class) → Level 2 (Acute/Chronic) → Level 3 (Subtype) → Output

**Design Tradeoffs**: Hierarchical approach improves accuracy for similar classes but adds complexity vs. flat classification; sequential inference ensures logical flow but may accumulate errors.

**Failure Signatures**: Data leakage from improper patient-based splitting; confusion between visually similar classes; ViT underperformance on small datasets.

**First Experiments**:
1. Implement flat baseline with ViT-Small and Focal Loss to establish performance benchmark
2. Test hierarchical model with isolated losses per level to verify cross-layer interference prevention
3. Compare ConvNeXt-Tiny vs. ViT-Small performance on the same task

## Open Questions the Paper Calls Out
- **Inter-observer variability comparison**: The paper suggests studying inter and intra-observer variability could offer comparative insights against real pathologists, as the current study doesn't benchmark against human diagnostic variability.
- **Geographic generalization**: The authors recommend gathering more data to enhance performance, implying concerns about generalization to different staining protocols and geographic regions.
- **Mixed-phenotype cases**: The hierarchical architecture assumes non-overlapping subgroups, which may not handle mixed-phenotype acute leukemias that exhibit features of multiple types.

## Limitations
- Dataset is not publicly available, preventing independent verification
- Exact hierarchical loss control mechanism is underspecified
- Several training hyperparameters (batch size, weight decay, Focal Loss γ/α) are missing

## Confidence
- **Methodology soundness**: Medium - well-structured but missing critical implementation details
- **Result validity**: Medium - competitive performance but lacks independent verification
- **Reproducibility**: Low - dataset access and key hyperparameters unavailable

## Next Checks
1. Implement and test the hierarchical loss isolation mechanism to ensure cross-level interference is prevented as claimed
2. Conduct ablation studies comparing flat vs. hierarchical models on a held-out validation set to verify reported precision/recall improvements
3. Replicate the ViT-Small vs. ConvNeXt-Tiny comparison using publicly available leukemia datasets (e.g., ALL_IDB) to assess architecture performance generalization